vs
黑莓（BB）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是黑莓的1.6倍（$219.9M vs $141.8M），黑莓净利率更高（9.7% vs -1.0%，领先10.7%），Orthofix Medical Inc.同比增速更快（2.0% vs -0.8%），黑莓自由现金流更多（$17.4M vs $16.8M），过去两年黑莓的营收复合增速更高（17.8% vs 8.0%）
黑莓有限公司（前身为动态研究公司，简称RIM）是加拿大专注于安全通信与物联网领域的软件企业，成立于1984年。早年曾推出黑莓品牌双向寻呼机、智能手机及平板电脑产品，后续转型提供软件与服务，拥有多项核心软件应用专利。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
BB vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.6倍
$141.8M
营收增速更快
OFIX
高出2.8%
-0.8%
净利率更高
BB
高出10.7%
-1.0%
自由现金流更多
BB
多$580.0K
$16.8M
两年增速更快
BB
近两年复合增速
8.0%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $141.8M | $219.9M |
| 净利润 | $13.7M | $-2.2M |
| 毛利率 | 77.5% | 71.1% |
| 营业利润率 | 8.4% | 0.2% |
| 净利率 | 9.7% | -1.0% |
| 营收同比 | -0.8% | 2.0% |
| 净利润同比 | 224.5% | 92.4% |
| 每股收益（稀释后） | $0.02 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BBOFIX
| Q4 25 | $141.8M | $219.9M | ||
| Q3 25 | $129.6M | $205.6M | ||
| Q2 25 | $121.7M | $203.1M | ||
| Q1 25 | $141.7M | $193.6M | ||
| Q4 24 | $143.6M | $215.7M | ||
| Q3 24 | $126.2M | $196.6M | ||
| Q2 24 | $123.4M | $198.6M | ||
| Q1 24 | $102.1M | $188.6M |
净利润BBOFIX
| Q4 25 | $13.7M | $-2.2M | ||
| Q3 25 | $13.3M | $-22.8M | ||
| Q2 25 | $1.9M | $-14.1M | ||
| Q1 25 | $-7.4M | $-53.1M | ||
| Q4 24 | $-10.5M | $-29.1M | ||
| Q3 24 | $-19.7M | $-27.4M | ||
| Q2 24 | $-41.4M | $-33.4M | ||
| Q1 24 | $-56.2M | $-36.0M |
毛利率BBOFIX
| Q4 25 | 77.5% | 71.1% | ||
| Q3 25 | 74.5% | 72.2% | ||
| Q2 25 | 74.2% | 68.7% | ||
| Q1 25 | 73.5% | 62.8% | ||
| Q4 24 | 78.1% | 69.0% | ||
| Q3 24 | 70.2% | 68.7% | ||
| Q2 24 | 72.9% | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率BBOFIX
| Q4 25 | 8.4% | 0.2% | ||
| Q3 25 | 8.9% | -8.3% | ||
| Q2 25 | 1.6% | -7.9% | ||
| Q1 25 | -5.6% | -25.2% | ||
| Q4 24 | 13.6% | -5.3% | ||
| Q3 24 | 1.7% | -9.6% | ||
| Q2 24 | -10.5% | -12.5% | ||
| Q1 24 | 50.0% | -15.6% |
净利率BBOFIX
| Q4 25 | 9.7% | -1.0% | ||
| Q3 25 | 10.3% | -11.1% | ||
| Q2 25 | 1.6% | -6.9% | ||
| Q1 25 | -5.2% | -27.4% | ||
| Q4 24 | -7.3% | -13.5% | ||
| Q3 24 | -15.6% | -13.9% | ||
| Q2 24 | -33.5% | -16.8% | ||
| Q1 24 | -55.0% | -19.1% |
每股收益（稀释后）BBOFIX
| Q4 25 | $0.02 | $-0.05 | ||
| Q3 25 | $0.02 | $-0.57 | ||
| Q2 25 | $0.00 | $-0.36 | ||
| Q1 25 | $-0.01 | $-1.35 | ||
| Q4 24 | $-0.02 | $-0.76 | ||
| Q3 24 | $-0.03 | $-0.71 | ||
| Q2 24 | $-0.07 | $-0.88 | ||
| Q1 24 | $-0.08 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.2M | $82.0M |
| 总债务越低越好 | $196.2M | — |
| 股东权益账面价值 | $741.1M | $450.0M |
| 总资产 | $1.2B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.26× | — |
8季度趋势，按日历期对齐
现金及短期投资BBOFIX
| Q4 25 | $304.2M | $82.0M | ||
| Q3 25 | $290.5M | $62.9M | ||
| Q2 25 | $306.6M | $65.6M | ||
| Q1 25 | $337.8M | $58.0M | ||
| Q4 24 | $220.0M | $83.2M | ||
| Q3 24 | $211.0M | $30.1M | ||
| Q2 24 | $229.0M | $26.4M | ||
| Q1 24 | $237.1M | $27.0M |
总债务BBOFIX
| Q4 25 | $196.2M | — | ||
| Q3 25 | $195.9M | $157.2M | ||
| Q2 25 | $195.6M | $157.0M | ||
| Q1 25 | $195.3M | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | $194.1M | $118.2M |
股东权益BBOFIX
| Q4 25 | $741.1M | $450.0M | ||
| Q3 25 | $725.1M | $442.5M | ||
| Q2 25 | $725.1M | $458.3M | ||
| Q1 25 | $719.9M | $458.3M | ||
| Q4 24 | $725.2M | $503.1M | ||
| Q3 24 | $732.1M | $525.9M | ||
| Q2 24 | $742.6M | $546.0M | ||
| Q1 24 | $775.1M | $570.3M |
总资产BBOFIX
| Q4 25 | $1.2B | $850.6M | ||
| Q3 25 | $1.2B | $832.6M | ||
| Q2 25 | $1.2B | $837.2M | ||
| Q1 25 | $1.3B | $823.1M | ||
| Q4 24 | $1.3B | $893.3M | ||
| Q3 24 | $1.3B | $867.9M | ||
| Q2 24 | $1.3B | $882.0M | ||
| Q1 24 | $1.4B | $906.0M |
负债/权益比BBOFIX
| Q4 25 | 0.26× | — | ||
| Q3 25 | 0.27× | 0.36× | ||
| Q2 25 | 0.27× | 0.34× | ||
| Q1 25 | 0.27× | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | 0.25× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.3M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $17.4M | $16.8M |
| 自由现金流率自由现金流/营收 | 12.3% | 7.6% |
| 资本支出强度资本支出/营收 | 0.6% | 4.9% |
| 现金转化率经营现金流/净利润 | 1.34× | — |
| 过去12个月自由现金流最近4个季度 | $42.8M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流BBOFIX
| Q4 25 | $18.3M | $27.7M | ||
| Q3 25 | $3.9M | $12.4M | ||
| Q2 25 | $-18.0M | $11.6M | ||
| Q1 25 | $41.6M | $-18.4M | ||
| Q4 24 | $6.0M | $23.7M | ||
| Q3 24 | $-16.0M | $11.7M | ||
| Q2 24 | $-15.1M | $9.0M | ||
| Q1 24 | $-15.5M | $-18.6M |
自由现金流BBOFIX
| Q4 25 | $17.4M | $16.8M | ||
| Q3 25 | $3.1M | $2.5M | ||
| Q2 25 | $-18.9M | $4.5M | ||
| Q1 25 | $41.2M | $-25.1M | ||
| Q4 24 | $5.2M | $15.2M | ||
| Q3 24 | $-16.5M | $6.3M | ||
| Q2 24 | $-16.5M | $-360.0K | ||
| Q1 24 | $-17.6M | $-29.1M |
自由现金流率BBOFIX
| Q4 25 | 12.3% | 7.6% | ||
| Q3 25 | 2.4% | 1.2% | ||
| Q2 25 | -15.5% | 2.2% | ||
| Q1 25 | 29.1% | -13.0% | ||
| Q4 24 | 3.6% | 7.0% | ||
| Q3 24 | -13.1% | 3.2% | ||
| Q2 24 | -13.4% | -0.2% | ||
| Q1 24 | -17.2% | -15.4% |
资本支出强度BBOFIX
| Q4 25 | 0.6% | 4.9% | ||
| Q3 25 | 0.6% | 4.8% | ||
| Q2 25 | 0.7% | 3.5% | ||
| Q1 25 | 0.3% | 3.5% | ||
| Q4 24 | 0.6% | 4.0% | ||
| Q3 24 | 0.4% | 2.7% | ||
| Q2 24 | 1.1% | 4.7% | ||
| Q1 24 | 2.1% | 5.6% |
现金转化率BBOFIX
| Q4 25 | 1.34× | — | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | -9.47× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BB
| QNX | $68.7M | 48% |
| Secure Communication | $67.0M | 47% |
| Licensing | $6.1M | 4% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
